Published in J Neurol on April 03, 2014
"Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res (1975) 301.74
Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry (1992) 33.67
The assessment of anxiety states by rating. Br J Med Psychol (1959) 24.58
Clinical diagnostic criteria for dementia associated with Parkinson's disease. Mov Disord (2007) 6.92
Prevalence of cerebral white matter lesions in elderly people: a population based magnetic resonance imaging study. The Rotterdam Scan Study. J Neurol Neurosurg Psychiatry (2001) 4.51
A scale for the assessment of hedonic tone the Snaith-Hamilton Pleasure Scale. Br J Psychiatry (1995) 3.89
Cognitive impairment in incident, untreated Parkinson disease: the Norwegian ParkWest study. Neurology (2008) 3.68
Non-motor symptoms of Parkinson's disease: dopaminergic pathophysiology and treatment. Lancet Neurol (2009) 3.62
Reliability, validity, and clinical correlates of apathy in Parkinson's disease. J Neuropsychiatry Clin Neurosci (1992) 3.21
The Mental Deterioration Battery: normative data, diagnostic reliability and qualitative analyses of cognitive impairment. The Group for the Standardization of the Mental Deterioration Battery. Eur Neurol (1996) 2.97
Neuropsychological and clinical heterogeneity of cognitive impairment and dementia in patients with Parkinson's disease. Lancet Neurol (2010) 2.69
L-Dopa medication remediates cognitive inflexibility, but increases impulsivity in patients with Parkinson's disease. Neuropsychologia (2003) 2.55
How does Parkinson's disease affect quality of life? A comparison with quality of life in the general population. Mov Disord (2000) 2.23
Nonmotor fluctuations in Parkinson's disease: frequent and disabling. Neurology (2002) 1.96
Progression of motor and nonmotor features of Parkinson's disease and their response to treatment. Br J Clin Pharmacol (2012) 1.39
Depression in Parkinson's disease. J Nerv Ment Dis (1990) 1.29
Impact of newer pharmacological treatments on quality of life in patients with Parkinson's disease. CNS Drugs (2008) 1.17
Role of dopamine in learning and memory: implications for the treatment of cognitive dysfunction in patients with Parkinson's disease. Drugs Aging (2000) 1.09
Frontal lobe dysfunction in secondary depression. J Neuropsychiatry Clin Neurosci (1994) 1.04
Effects of the dopamine agonist pramipexole on depression, anhedonia and motor functioning in Parkinson's disease. J Neurol Sci (2006) 1.02
Non-motor symptoms in early Parkinson's disease: a 2-year follow-up study on previously untreated patients. J Neurol Neurosurg Psychiatry (2012) 1.00
Nonmotor symptoms in de novo Parkinson disease before and after dopaminergic treatment. J Neurol Sci (2009) 0.99
Chronic effects of dopaminergic replacement on cognitive function in Parkinson's disease: a two-year follow-up study of previously untreated patients. Mov Disord (2000) 0.96
Dopamine and cognitive functioning in de novo subjects with Parkinson's disease: effects of pramipexole and pergolide on working memory. Neuropsychologia (2009) 0.93
The syndromal validity and nosological position of apathy in Parkinson's disease. Mov Disord (2009) 0.90
Depression in Parkinson's disease: diagnosis and treatment. Arq Neuropsiquiatr (2012) 0.89
Link between non-motor symptoms and cognitive dysfunctions in de novo, drug-naive PD patients. J Neurol (2012) 0.88
Early-stage cognitive impairment in Parkinson's disease and the influence of dopamine replacement therapy. Eur J Neurol (2011) 0.84
Deficit of short-term memory in newly diagnosed untreated parkinsonian patients: reversal after L-dopa therapy. Neurol Sci (2003) 0.79
Event-based prospective memory in newly diagnosed, drug-naive Parkinson's disease patients. J Int Neuropsychol Soc (2011) 0.79
Mild affective symptoms in de novo Parkinson's disease patients: relationship with dopaminergic dysfunction. Eur J Neurol (2012) 0.78
Relationship between neuropsychiatric symptoms and cognitive performance in de novo Parkinson's disease. J Neuropsychiatry Clin Neurosci (2012) 0.77
Mood disorders in the medically ill: scientific review and recommendations. Biol Psychiatry (2005) 4.81
Bilateral deep brain stimulation of the pedunculopontine and subthalamic nuclei in severe Parkinson's disease. Brain (2007) 4.13
Developmental cascades: linking academic achievement and externalizing and internalizing symptoms over 20 years. Dev Psychol (2005) 4.01
Implantation of human pedunculopontine nucleus: a safe and clinically relevant target in Parkinson's disease. Neuroreport (2005) 3.80
The PRIAMO study: A multicenter assessment of nonmotor symptoms and their impact on quality of life in Parkinson's disease. Mov Disord (2009) 3.56
Mortality and poststroke depression: a placebo-controlled trial of antidepressants. Am J Psychiatry (2003) 3.41
Deep brain stimulation for Parkinson disease: an expert consensus and review of key issues. Arch Neurol (2010) 2.64
Eliminating tobacco-related health disparities: directions for future research. Am J Public Health (2004) 2.50
Developmental changes in hypothalamus-pituitary-adrenal activity over the transition to adolescence: normative changes and associations with puberty. Dev Psychopathol (2009) 2.37
Discontinuation of statin therapy and clinical outcome after ischemic stroke. Stroke (2007) 2.07
Resources and resilience in the transition to adulthood: continuity and change. Dev Psychopathol (2004) 2.06
Effects of a novel schizophrenia risk variant rs7914558 at CNNM2 on brain structure and attributional style. Br J Psychiatry (2013) 2.06
Indexing disease progression at study entry with individuals at-risk for Huntington disease. Am J Med Genet B Neuropsychiatr Genet (2011) 2.05
Magnetic resonance imaging markers of Parkinson's disease nigrostriatal signature. Brain (2010) 2.01
Cardiac autonomic derangement and arrhythmias in right-sided stroke with insular involvement. Stroke (2004) 1.97
Major depression following traumatic brain injury. Arch Gen Psychiatry (2004) 1.88
The Alzheimer's Association external quality control program for cerebrospinal fluid biomarkers. Alzheimers Dement (2011) 1.87
Volume and iron content in basal ganglia and thalamus. Hum Brain Mapp (2009) 1.85
Inverse occurrence of cancer and Alzheimer disease: a population-based incidence study. Neurology (2013) 1.70
Posterior tibial nerve stimulation in the treatment of urge incontinence. Neurourol Urodyn (2003) 1.67
Effect of antidepressants on the course of disability following stroke. Am J Geriatr Psychiatry (2011) 1.65
Mapping local hippocampal changes in Alzheimer's disease and normal ageing with MRI at 3 Tesla. Brain (2008) 1.61
Chronic ketamine use increases serum levels of brain-derived neurotrophic factor. Psychopharmacology (Berl) (2010) 1.57
The assessment of newborn iron stores at birth: a review of the literature and standards for ferritin concentrations. Neonatology (2007) 1.56
The marketing of menthol cigarettes in the United States: populations, messages, and channels. Nicotine Tob Res (2004) 1.54
Role of blebs and bullae detected by high-resolution computed tomography and recurrent spontaneous pneumothorax. Ann Thorac Surg (2012) 1.54
The interplay of social competence and psychopathology over 20 years: testing transactional and cascade models. Child Dev (2008) 1.53
Neuropsychiatric predictors of progression from amnestic-mild cognitive impairment to Alzheimer's disease: the role of depression and apathy. J Alzheimers Dis (2010) 1.52
Effects of deep brain stimulation of the peduncolopontine area on working memory tasks in patients with Parkinson's disease. Parkinsonism Relat Disord (2009) 1.45
Plasma dehydroepiandrosterone levels are strongly increased in schizophrenia. J Psychiatr Res (2005) 1.44
The construct of minor and major depression in Alzheimer's disease. Am J Psychiatry (2005) 1.43
Retrograde episodic and semantic memory impairment correlates with side of temporal lobe damage. J Int Neuropsychol Soc (2008) 1.42
Recognition memory for single items and for associations in amnesic patients. Neuropsychologia (2004) 1.35
Clinical correlates of aggressive behavior after traumatic brain injury. J Neuropsychiatry Clin Neurosci (2003) 1.34
White matter volume and cognitive dysfunction in early Huntington's disease. Cogn Behav Neurol (2005) 1.34
The structure and invariance of a model of social functioning in schizophrenia. J Nerv Ment Dis (2002) 1.33
Repetitive TMS of cerebellum interferes with millisecond time processing. Exp Brain Res (2006) 1.32
Focal stimulation of the posterior parietal cortex increases the excitability of the ipsilateral motor cortex. J Neurosci (2007) 1.31
The cerebellum and emotional experience. Neuropsychologia (2006) 1.31
Hyperexcitability of parietal-motor functional connections in the intact left-hemisphere of patients with neglect. Brain (2008) 1.30
Academic achievement of homeless and highly mobile children in an urban school district: longitudinal evidence on risk, growth, and resilience. Dev Psychopathol (2009) 1.28
Psychosocial functioning improves following adolescent bariatric surgery. Obesity (Silver Spring) (2009) 1.27
Hippocampal volume reduction in first-episode and chronic schizophrenia: a review and meta-analysis. Neuroscientist (2011) 1.27
Changes in intracortical circuits of the human motor cortex following theta burst stimulation of the lateral cerebellum. Clin Neurophysiol (2008) 1.27
Neural networks engaged in milliseconds and seconds time processing: evidence from transcranial magnetic stimulation and patients with cortical or subcortical dysfunction. Philos Trans R Soc Lond B Biol Sci (2009) 1.27
Perceiving numbers alters time perception. Neurosci Lett (2008) 1.26
Apathy following stroke. Can J Psychiatry (2010) 1.26
In vivo structural neuroanatomy of corpus callosum in Alzheimer's disease and mild cognitive impairment using different MRI techniques: a review. J Alzheimers Dis (2010) 1.24
Measuring interpersonal callousness in boys from childhood to adolescence: an examination of longitudinal invariance and temporal stability. J Clin Child Adolesc Psychol (2007) 1.23
A longitudinal investigation of visual event-related potentials in the first year of life. Dev Sci (2005) 1.22
Construct validity of a measure of subjective satisfaction with life of adults with serious mental illness. Psychiatr Serv (2005) 1.21
Functional changes in the activity of cerebellum and frontostriatal regions during externally and internally timed movement in Parkinson's disease. Brain Res Bull (2006) 1.20
Vascular thalamic amnesia: a reappraisal. Neuropsychologia (2011) 1.20
Curriculum-based measurement oral reading as an indicator of reading achievement: a meta-analysis of the correlational evidence. J Sch Psychol (2009) 1.18
Relativistic compression and expansion of experiential time in the left and right space. PLoS One (2008) 1.18
European consensus on a competency-based virtual reality training program for basic endoscopic surgical psychomotor skills. Surg Endosc (2010) 1.17
Prefrontal-thalamic-cerebellar gray matter networks and executive functioning in schizophrenia. Schizophr Res (2007) 1.17
Increased facilitation of the primary motor cortex following 1 Hz repetitive transcranial magnetic stimulation of the contralateral cerebellum in normal humans. Neurosci Lett (2004) 1.17
Neuropsychiatric symptoms and syndromes in a large cohort of newly diagnosed, untreated patients with Alzheimer disease. Am J Geriatr Psychiatry (2010) 1.16
Aging of subcortical nuclei: microstructural, mineralization and atrophy modifications measured in vivo using MRI. Neuroimage (2009) 1.16
Prognostic implications of right-sided insular damage, cardiac autonomic derangement, and arrhythmias after acute ischemic stroke. Stroke (2005) 1.15
Underestimation of time perception after repetitive transcranial magnetic stimulation. Neurology (2003) 1.15
Mutations of the Nogo-66 receptor (RTN4R) gene in schizophrenia. Hum Mutat (2004) 1.14
Resonance of cortico-cortical connections of the motor system with the observation of goal directed grasping movements. Neuropsychologia (2010) 1.14
Callosal atrophy in mild cognitive impairment and Alzheimer's disease: different effects in different stages. Neuroimage (2009) 1.13
Early deprivation and home basal cortisol levels: a study of internationally adopted children. Dev Psychopathol (2008) 1.13
rTMS evidence of different delay and decision processes in a fronto-parietal neuronal network activated during spatial working memory. Neuroimage (2005) 1.13
Defining and diagnosing involuntary emotional expression disorder. CNS Spectr (2006) 1.12
Functional interplay between posterior parietal and ipsilateral motor cortex revealed by twin-coil transcranial magnetic stimulation during reach planning toward contralateral space. J Neurosci (2008) 1.12
Differential post-translational modifications of transthyretin in Alzheimer's disease: a study of the cerebral spinal fluid. Proteomics (2006) 1.11
Early and long-term outcome of rehabilitation in stroke patients: the role of patient characteristics, time of initiation, and duration of interventions. Arch Phys Med Rehabil (2003) 1.11
Refining the diagnosis of Huntington disease: the PREDICT-HD study. Front Aging Neurosci (2013) 1.10
Grey and white matter changes at different stages of Alzheimer's disease. J Alzheimers Dis (2010) 1.10
Impaired reproduction of second but not millisecond time intervals in Parkinson's disease. Neuropsychologia (2007) 1.10
Gender-related effect of clinical and genetic variables on the cognitive impairment in multiple sclerosis. J Neurol (2004) 1.10
Academic achievement trajectories of homeless and highly mobile students: resilience in the context of chronic and acute risk. Child Dev (2012) 1.09
Striatal volume contributes to the prediction of onset of Huntington disease in incident cases. Biol Psychiatry (2011) 1.09
Increased blood-cerebrospinal fluid transfer of albumin in advanced Parkinson's disease. J Neuroinflammation (2012) 1.08
Alzheimer's disease and frontal variant of frontotemporal dementia-- a very brief battery for cognitive and behavioural distinction. J Neurol (2005) 1.08
Treatment of vascular depression using repetitive transcranial magnetic stimulation. Arch Gen Psychiatry (2008) 1.08
Cognitive decline in prodromal Huntington Disease: implications for clinical trials. J Neurol Neurosurg Psychiatry (2013) 1.07
Age-related differences in the production of textual descriptions. J Psycholinguist Res (2005) 1.07
Long-term effects on cortical excitability and motor recovery induced by repeated muscle vibration in chronic stroke patients. Neurorehabil Neural Repair (2010) 1.07
Forward and backward span for verbal and visuo-spatial data: standardization and normative data from an Italian adult population. Neurol Sci (2012) 1.07
In vivo definition of parieto-motor connections involved in planning of grasping movements. Neuroimage (2010) 1.06
Re: Stereotactic microdialysis of the basal ganglia in Parkinson's disease. J Neurosci Methods (2013) 1.06
Nutritional practices in the neonatal intensive care unit: analysis of a 2006 neonatal nutrition survey. Pediatrics (2009) 1.06
Hemiparkinsonism due to frontal meningioma. Acta Neurol Belg (2008) 1.06
Non-motor symptoms in atypical and secondary parkinsonism: the PRIAMO study. J Neurol (2009) 1.05
Long-term effects on motor cortical excitability induced by repeated muscle vibration during contraction in healthy subjects. J Neurol Sci (2008) 1.05
Neuropsychological performance is associated with vascular function in patients with atherosclerotic vascular disease. Arterioscler Thromb Vasc Biol (2006) 1.05
Blood vessel function and cognition in elderly patients with atherosclerosis. Stroke (2004) 1.05
Interactions between pairs of transcranial magnetic stimuli over the human left dorsal premotor cortex differ from those seen in primary motor cortex. J Physiol (2006) 1.05
Education mediates microstructural changes in bilateral hippocampus. Hum Brain Mapp (2011) 1.05